Your browser doesn't support javascript.
loading
Half-dose ocrelizumab in selected patients with relapsing-remitting multiple sclerosis.
Algahtani, Hussein; Shirah, Bader; Alqahtani, Abdulhadi; Abdelghaffar, Nawal; Makki, Samiah.
Affiliation
  • Algahtani H; Department of Medicine, Aseer Central Hospital, Abha, Saudi Arabia. halgahtani@hotmail.com.
  • Shirah B; Neurology Section, Department of Medicine, King Abdulaziz Medical City, P.O. Box: 12723, Jeddah, 21483, Saudi Arabia. halgahtani@hotmail.com.
  • Alqahtani A; Department of Neuroscience, King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia.
  • Abdelghaffar N; College of Medicine, King Khalid University, Abha, Saudi Arabia.
  • Makki S; Department of Medicine, Aseer Central Hospital, Abha, Saudi Arabia.
Acta Neurol Belg ; 124(1): 303-306, 2024 Feb.
Article in En | MEDLINE | ID: mdl-37301802
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Chronic Progressive / Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Limits: Humans Language: En Journal: Acta Neurol Belg Year: 2024 Document type: Article Affiliation country: Saudi Arabia Country of publication: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Chronic Progressive / Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Limits: Humans Language: En Journal: Acta Neurol Belg Year: 2024 Document type: Article Affiliation country: Saudi Arabia Country of publication: Italy